Survey of Palliative Sedation at End of Life in Terminally Ill Heart Failure Patients　― A Single-Center Experience of 5-Year Follow-up

Background:Little is known about palliative sedation in terminally ill heart failure (HF) patients.Methods and Results:We retrospectively reviewed terminally ill HF patients who received palliative sedation from September 2013 to August 2018. Among 95 terminally ill HF patients, 25 were prescribed d...

Full description

Saved in:
Bibliographic Details
Published in:Circulation Journal 2019/06/25, Vol.83(7), pp.1607-1611
Main Authors: Hamatani, Yasuhiro, Nakai, Eri, Nakamura, Emi, Miyata, Michi, Kawano, Yukie, Takada, Yasuko, Anchi, Yuta, Funabashi, Sayaka, Hirayama, Atsushi, Kuroda, Kensuke, Amano, Masashi, Sugano, Yasuo, Anzai, Toshihisa, Izumi, Chisato
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Dexmedetomidine - administration & dosage
Female
Follow-Up Studies
Heart failure
Heart Failure - therapy
Humans
Male
Midazolam - administration & dosage
Middle Aged
Palliative Care
Retrospective Studies
Sedation
Terminal Care
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background:Little is known about palliative sedation in terminally ill heart failure (HF) patients.Methods and Results:We retrospectively reviewed terminally ill HF patients who received palliative sedation from September 2013 to August 2018. Among 95 terminally ill HF patients, 25 were prescribed dexmedetomidine and 12 were prescribed midazolam at the end of life. Richmond Agitation-Sedation Scale was significantly reduced (P
ISSN:1346-9843
1347-4820
1347-4820
DOI:10.1253/circj.CJ-19-0125